The variation levels and the subcellular redistribution of AmotL2 shown in this study in tumor cells, metastasis and blood vessels and adjacent cells are indicative of its involvement in the CRC tumorigenesis and progression processes. The gene discussed is AMOTL2; the disease is colorectal carcinoma.